Remote Buying of ALPS Medical Breakthroughs ETF through IEX is under development on ETFS.com.
Notify Me when it is readyRemote Selling of ALPS Medical Breakthroughs ETF through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
SPDR Biotech ETF: Medical Science Is Gradually Becoming Stronger Than COVID-19 via Seeking Alpha
‘The medical community has learnt a lot’ and are ‘better prepared’ for the next phase: doctor via Yahoo Finance
Trump tweets: 'I will be leaving the great Walter Reed Medical Center today at 6:30 P.M.' via MSNBC
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Analysis is available when the exchange & market are open.